Edges in Network
| Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | PTAFR |
| Upstream (Parents) |
|---|
| (<<) CAMKK2 → PTAFR |
| (<<) CSNK1D → PTAFR |
| (<<) DMPK → PTAFR |
| (<<) GALK1 → PTAFR |
| (<<) GRHPR → PTAFR |
| (<<) MT1P2 → PTAFR |
| (<<) NOS3 → PTAFR |
| (<<) NRAS → PTAFR |
| (<<) NRIP1 → PTAFR |
| (<<) PLD2 → PTAFR |
| (<<) PTEN → PTAFR |
| (<<) RHOF → PTAFR |
| (<<) ROCK2 → PTAFR |
| (<<) SALL2 → PTAFR |
| (<<) SET → PTAFR |
| (<<) SMAD7 → PTAFR |
| (<<) TCOF1 → PTAFR |
| (<<) TRAF2 → PTAFR |
| (<<) UBE2D2 → PTAFR |
| (<<) VAV1 → PTAFR |
| Downstream (Children) |
|---|
| PTAFR → CAT (>>) |
| PTAFR → CEBPE (>>) |
| PTAFR → NMU (>>) |
| PTAFR → PRKCA (>>) |
| PTAFR → SLC5A1 (>>) |
| PTAFR → SOCS1 (>>) |
